The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Specific Cleavage of Mcl-1 by Caspase-3 in Tumor Necrosis Factor-related Apoptosis-inducing Ligand (TRAIL)-induced Apoptosis in Jurkat Leukemia T Cells
Open accessAbstract
Tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) induces programmed cell death through the caspase activation cascade and translocation of cleaved Bid (tBid) by the apical caspase-8 to mitochondria to induce oligomerization of multidomain Bax and Bak. However, the roles of prosurvival Bcl-2 family proteins in TRAIL apoptosis remain elusive. Here we showed that, besides the specific cleavage and activation of Bid by caspase-8 and caspase-3, TRAIL-induced apoptosis in Jurkat T cells required the specific cleavage of Mcl-1 at Asp-127 and Asp-157 by caspase-3, while other prototypic antiapoptotic factors such as Bcl-2 or Bcl-X(L) seemed not to be affected. Mutation at Asp-127 and Asp-157 of Mcl-1 led to cellular resistance to TRAIL-induced apoptosis. In sharp contrast to cycloheximide-induced Mcl-1 dilapidation, TRAIL did not activate proteasomal degradation of Mcl-1 in Jurkat cells. We further established for the first time that the C-terminal domain of Mcl-1 became proapoptotic as a result of caspase-3 cleavage, and its physical interaction and cooperation with tBid, Bak, and voltage-dependent anion-selective channel 1 promoted mitochondrial apoptosis. These results suggested that removal of N-terminal domains of Bid by caspase-8 and Mcl-1 by caspase-3 enabled the maximal mitochondrial perturbation that potentiated TRAIL-induced apoptosis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Green, D. R., & Reed, J. C. (1998) · Science · doi:10.1126/science.281.5381.1309 · Cited by 8,965
Thornberry, N. A., & Lazebnik, Y. (1998) · Science · doi:10.1126/science.281.5381.1312 · Cited by 6,887
Death Receptors: Signaling and Modulation
Ashkenazi, A., & Dixit, V. M. (1998) · Science · doi:10.1126/science.281.5381.1305 · Cited by 5,866
The Bcl-2 Protein Family: Arbiters of Cell Survival
Adams, J. M., & Cory, S. (1998) · Science · doi:10.1126/science.281.5381.1322 · Cited by 5,332
Cleavage of BID by Caspase 8 Mediates the Mitochondrial Damage in the Fas Pathway of Apoptosis
Li, H., Zhu, H., Xu, C.-J., & Yuan, J. (1998) · Cell · doi:10.1016/s0092-8674(00)81590-1 · Cited by 4,445
BCL-2 family members and the mitochondria in apoptosis
Gross, A., McDonnell, J. M., & Korsmeyer, S. J. (1999) · Genes & Development · doi:10.1101/gad.13.15.1899 · Cited by 3,641
Luo, X., Budihardjo, I., Zou, H., Slaughter, C., & Wang, X. (1998) · Cell · doi:10.1016/s0092-8674(00)81589-5 · Cited by 3,626
Mitochondrial control of cell death
Kroemer, G., & Reed, J. C. (2000) · Nature Medicine · doi:10.1038/74994 · Cited by 3,103
Identification and characterization of a new member of the TNF family that induces apoptosis
Wiley, S. R., Schooley, K., Smolak, P. J., Din, W. S., Huang, C.-P., Nicholl, J. K., Sutherland, G. R., Smith, T. D., Rauch, C., Smith, C. A., et al. (1995) · Immunity · doi:10.1016/1074-7613(95)90057-8 · Cited by 2,900
(2001) · PubMed · Cited by 2,381
Mechanisms of Caspase Activation and Inhibition during Apoptosis
Shi, Y. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00482-3 · Cited by 1,833
Self-citationVeis, D. J., Sorenson, C. M., Shutter, J. R., & Korsmeyer, S. J. (1993) · Cell · doi:10.1016/0092-8674(93)80065-m · Cited by 1,628
tBID, a membrane-targeted death ligand, oligomerizes BAK to release cytochrome c
Wei, M. C., Lindsten, T., Mootha, V. K., Weiler, S., Gross, A., Ashiya, M., Thompson, C. B., & Korsmeyer, S. J. (2000) · Genes & Development · doi:10.1101/gad.14.16.2060 · Cited by 1,268
Desagher, S., Osen-Sand, A., Nichols, A., Eskes, R., Montessuit, S., Lauper, S., Maundrell, K., Antonsson, B., & Martinou, J.-C. (1999) · The Journal of Cell Biology · doi:10.1083/jcb.144.5.891 · Cited by 1,262
Varfolomeev, E. E., Schuchmann, M., Luria, V., Chiannilkulchai, N., Beckmann, J. S., Mett, I. L., Rebrikov, D., Brodianski, V. M., Kemper, O. C., Kollet, O., et al. (1998) · Immunity · doi:10.1016/s1074-7613(00)80609-3 · Cited by 1,234
Massive Cell Death of Immature Hematopoietic Cells and Neurons in Bcl-x-Deficient Mice
Motoyama, N., Wang, F., Roth, K. A., Sawa, H., Nakayama, K.-I., Nakayama, K., Negishi, I., Senju, S., Zhang, Q., Fujii, S., et al. (1995) · Science · doi:10.1126/science.7878471 · Cited by 1,163
Conversion of Bcl-2 to a Bax-like Death Effector by Caspases
Cheng, E. H.-Y., Kirsch, D. G., Clem, R. J., Ravi, R., Kastan, M. B., Bedi, A., Ueno, K., & Hardwick, J. M. (1997) · Science · doi:10.1126/science.278.5345.1966 · Cited by 1,107
BH3-Only Proteins—Essential Initiators of Apoptotic Cell Death
Huang, D. C. S., & Strasser, A. (2000) · Cell · doi:10.1016/s0092-8674(00)00187-2 · Cited by 1,043
Many cuts to ruin: a comprehensive update of caspase substrates
Fischer, U., Jänicke, R. U., & Schulze-Osthoff, K. (2003) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401160 · Cited by 1,029
Apo2L/TRAIL-Dependent Recruitment of Endogenous FADD and Caspase-8 to Death Receptors 4 and 5
Kischkel, F. C., Lawrence, D. A., Chuntharapai, A., Schow, P., Kim, K. J., & Ashkenazi, A. (2000) · Immunity · doi:10.1016/s1074-7613(00)80212-5 · Cited by 975
MCL1, a gene expressed in programmed myeloid cell differentiation, has sequence similarity to BCL2.
Kozopas, K. M., Yang, T., Buchan, H. L., Zhou, P., & Craig, R. W. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.8.3516 · Cited by 961
Breaking the mitochondrial barrier
Martinou, J.-C., & Green, D. R. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35048069 · Cited by 946
BID: a novel BH3 domain-only death agonist.
Wang, K., Yin, X. M., Chao, D. T., Milliman, C. L., & Korsmeyer, S. J. (1996) · Genes & Development · doi:10.1101/gad.10.22.2859 · Cited by 946
FADD: Essential for Embryo Development and Signaling from Some, But Not All, Inducers of Apoptosis
Yeh, W.-C., Pompa, J. L. D. L., McCurrach, M. E., Shu, H.-B., Elia, A. J., Shahinian, A., Ng, M., Wakeham, A., Khoo, W., Mitchell, K., et al. (1998) · Science · doi:10.1126/science.279.5358.1954 · Cited by 893
Cleavage of the death domain kinase RIP by Caspase-8 prompts TNF-induced apoptosis
Lin, Y., Devin, A., Rodriguez, Y., & Liu, Z.-G. (1999) · Genes & Development · doi:10.1101/gad.13.19.2514 · Cited by 836
Development and maintenance of B and T lymphocytes requires antiapoptotic MCL-1
Opferman, J. T., Letai, A., Beard, C., Sorcinelli, M. D., Ong, C. C., & Korsmeyer, S. J. (2003) · Nature · doi:10.1038/nature02067 · Cited by 801
Zhang, J., Cado, D., Chen, A., Kabra, N. H., & Winoto, A. (1998) · Nature · doi:10.1038/32681 · Cited by 706
Bcl‐2 family: Life‐or‐death switch
Tsujimoto, Y., & Shimizu, S. (2000) · FEBS Letters · doi:10.1016/s0014-5793(99)01761-5 · Cited by 667
Bcl-2 proteins: regulators of apoptosis or of mitochondrial homeostasis?
Vander Heiden, M. G., & Thompson, C. B. (1999) · Nature Cell Biology · doi:10.1038/70237 · Cited by 659
Elimination of Mcl-1 is required for the initiation of apoptosis following ultraviolet irradiation
Nijhawan, D., Fang, M., Traer, E., Zhong, Q., Gao, W., Du, F., & Wang, X. (2003) · Genes & Development · doi:10.1101/gad.1093903 · Cited by 591
Apoptosis in the development and maintenance of the immune system
Opferman, J. T., & Korsmeyer, S. J. (2003) · Nature Immunology · doi:10.1038/ni0503-410 · Cited by 526
Modulation of cell death by Bcl-x L through caspase interaction
Clem, R. J., Cheng, E. H.-Y., Karp, C. L., Kirsch, D. G., Ueno, K., Takahashi, A., Kastan, M. B., Griffin, D. E., Earnshaw, W. C., Veliuona, M. A., et al. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.2.554 · Cited by 514
Control of Apoptosis in the Immune System: Bcl-2, BH3-Only Proteins and More
Marsden, V. S., & Strasser, A. (2003) · Annual Review of Immunology · doi:10.1146/annurev.immunol.21.120601.141029 · Cited by 384
THE CENTRAL EFFECTORS OF CELL DEATH IN THE IMMUNE SYSTEM
Rathmell, J. C., & Thompson, C. B. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.781 · Cited by 379
A structural view of mitochondria-mediated apoptosis.
Shi, Y. (2001) · Nature Structural Biology · doi:10.1038/87548 · Cited by 348
Self-citationDefective thymocyte apoptosis and accelerated autoimmune diseases in TRAIL−/− mice
Lamhamedi-Cherradi, S.-E., Zheng, S.-J., Maguschak, K. A., Peschon, J., & Chen, Y. H. (2003) · Nature Immunology · doi:10.1038/ni894 · Cited by 348
DNA damage response and MCL-1 destruction initiate apoptosis in adenovirus-infected cells
Cuconati, A., Mukherjee, C., Perez, D., & White, E. (2003) · Genes & Development · doi:10.1101/gad.1156903 · Cited by 315
Sytwu, H.-K., Liblau, R. S., & McDevitt, H. O. (1996) · Immunity · doi:10.1016/s1074-7613(00)80306-4 · Cited by 305
TRAIL/Apo-2L: Mechanisms and Clinical Applications in Cancer
Srivastava, R. K. (2001) · Neoplasia · doi:10.1038/sj.neo.7900203 · Cited by 280
Slee, E. A., Keogh, S. A., & Martin, S. J. (2000) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400689 · Cited by 272
Mittl, P. R. E., Di Marco, S., Krebs, J. F., Bai, X., Karanewsky, D. S., Priestle, J. P., Tomaselli, K. J., & Grütter, M. G. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.10.6539 · Cited by 250
Bclx regulates the survival of double-positive thymocytes.
Ma, A., Pena, J. C., Chang, B., Margosian, E., Davidson, L., Alt, F. W., & Thompson, C. B. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.11.4763 · Cited by 244
Taniai, M., Grambihler, A., Higuchi, H., Werneburg, N., Bronk, S. F., Farrugia, D. J., Kaufmann, S. H., & Gores, G. J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2770 · Cited by 218
Enhanced and accelerated lymphoproliferation in Fas-null mice.
Adachi, M., Suematsu, S., Suda, T., Watanabe, D., Fukuyama, H., Ogasawara, J., Tanaka, T., Yoshida, N., & Nagata, S. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.5.2131 · Cited by 203
Zheng, Y., Shi, Y., Tian, C., Jiang, C., Jin, H., Chen, J., Almasan, A., Tang, H., & Chen, Q. (2004) · Oncogene · doi:10.1038/sj.onc.1207205 · Cited by 199
Self-citationUbiquitin-mediated Degradation of the Proapoptotic Active Form of Bid
Breitschopf, K., Zeiher, A. M., & Dimmeler, S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001083200 · Cited by 199
Cleavage of Mcl-1 by caspases impaired its ability to counteract Bim-induced apoptosis
Herrant, M., Jacquel, A., Marchetti, S., Belhacène, N., Colosetti, P., Luciano, F., & Auberger, P. (2004) · Oncogene · doi:10.1038/sj.onc.1208069 · Cited by 178
Li, P., Lee, H., Guo, S., Unterman, T. G., Jenster, G., & Bai, W. (2003) · Molecular and Cellular Biology · doi:10.1128/mcb.23.1.104-118.2003 · Cited by 160
Shi, Y., Chen, J., Weng, C., Chen, R., Zheng, Y., Chen, Q., & Tang, H. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/s0006-291x(03)00871-4 · Cited by 158
Michels, J., O’Neill, J., Dallman, C., Mouzakiti, A., Habens, F., Brimmell, M., Zhang, K. Y. J., Craig, R. W., Marcusson, E. G., Johnson, P., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1207648 · Cited by 145
Xu, Y., Martin, S., James, D. E., & Hong, W. (2002) · Molecular Biology of the Cell · doi:10.1091/mbc.e02-01-0004 · Cited by 138
Degradation of Mcl-1 by Granzyme B
Han, J., Goldstein, L. A., Gastman, B., Froelich, C. J., Yin, X., & Rabinowich, H. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m313234200 · Cited by 125
Bannerman, D. D., Tupper, J. C., Ricketts, W. A., Bennett, C. F., Winn, R. K., & Harlan, J. M. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m100819200 · Cited by 111
Cheng, H., Shih, H., & Chern, Y. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m201206200 · Cited by 90
Characterisation of Mcl‐1 cleavage during apoptosis of haematopoietic cells
Clohessy, J. G., Zhuang, J., & Brady, H. J. M. (2004) · British Journal of Haematology · doi:10.1111/j.1365-2141.2004.04949.x · Cited by 84
Page, D. M., Roberts, E. M., Peschon, J. J., & Hedrick, S. Μ. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.1.120 · Cited by 80
Transcriptional and translational control of Mcl-1 during apoptosis
Iglesias‐Serret, D., Piqué, M., Gil, J., Pons, G., & López, J. M. (2003) · Archives of Biochemistry and Biophysics · doi:10.1016/s0003-9861(03)00345-x · Cited by 71
Cited by
Mitochondrial membrane permeabilization in cell death
Kroemer, G., Galluzzi, L., & Brenner, C. (2007) · Physiological Reviews · doi:10.1152/physrev.00013.2006 · Cited by 3,598
Zhong, Q., Gao, W., Du, F., & Wang, X. (2005) · Cell · doi:10.1016/j.cell.2005.06.009 · Cited by 842
Mcl‐1; the molecular regulation of protein function
Thomas, L. W., Lam, C., & Edwards, S. W. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.05.061 · Cited by 538
Mcl-1 is a potential therapeutic target in multiple types of cancer
Akgul, C. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-008-8637-6 · Cited by 329
Rahmani, M., Davis, E. M., Bauer, C., Dent, P., & Grant, S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m506551200 · Cited by 288
Metadata
- Authors
- Weng, C., Li, Y., Xu, D., Shi, Y., & Tang, H.
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2005-03
- Volume
- 280
- Issue
- 11
- Pages
- 10491-10500
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2111871531
- Cited by
- 254
- References
- 57
- FWCI
- 5.76
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.